Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.94 USD | -1.59% | -10.18% | -12.10% |
Mar. 15 | Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. | CI |
Mar. 13 | Craig-Hallum Downgrades Champions Oncology to Hold From Buy | MT |
Financials (USD)
Sales 2024 * | 48.84M | Sales 2025 * | 53.68M | Capitalization | 67.15M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.37 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.25 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.79% |
Latest transcript on Champions Oncology, Inc.
1 day | -1.59% | ||
1 week | -10.18% | ||
Current month | -16.27% | ||
1 month | -11.31% | ||
3 months | -6.70% | ||
6 months | -14.53% | ||
Current year | -12.10% |
Managers | Title | Age | Since |
---|---|---|---|
Ronnie Morris
CEO | Chief Executive Officer | 58 | 10-10-25 |
Brady Davis
PSD | President | - | 23-10-16 |
Joel Ackerman
CHM | Chairman | 59 | 10-10-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
FOU | Founder | 64 | 07-12-31 |
Scott Tobin
BRD | Director/Board Member | 53 | 11-06-26 |
Joel Ackerman
CHM | Chairman | 59 | 10-10-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 4.94 | -1.59% | 937 |
24-03-26 | 5.02 | -3.46% | 5,272 |
24-03-25 | 5.2 | -3.70% | 6,935 |
24-03-22 | 5.4 | +1.50% | 4,202 |
24-03-21 | 5.32 | -3.27% | 2,383 |
Delayed Quote Nasdaq, March 27, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-12.10% | 67.15M | |
+9.16% | 45.97B | |
+54.09% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |